Press Releases
Beyond capacity: biopharma companies need agile manufacturing partners
Agility is more than speed.
For a CDMO, it means building technical capabilities to meet evolving biopharmaceutical demand as well as assuring clients that manufacturing plants will be ready when they need it.
James Choi, Executive Vice President, Chief Marketing Officer, and Head of Project Management and Global Public Affairs, discusses key characteristics CDMOs should adopt to achieve client satisfaction with the Manufacturing Chemist.
Agility is more than speed.
For a CDMO, it means building technical capabilities to meet evolving biopharmaceutical demand as well as assuring clients that manufacturing plants will be ready when they need it.
James Choi, Executive Vice President, Chief Marketing Officer, and Head of Project Management and Global Public Affairs, discusses key characteristics CDMOs should adopt to achieve client satisfaction with the Manufacturing Chemist.